1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Preclinical CRO Market
2.2. Global Preclinical CRO Market, By Service, 2023 (US$ Million)
2.3. Global Preclinical CRO Market, By Model Type, 2023 (US$ Million)
2.4. Global Preclinical CRO Market, By End-Use, 2023 (US$ Million)
2.5. Global Preclinical CRO Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Preclinical CRO Market: Competitive Analysis
3.1. Market Positioning of Key Preclinical CRO Market Vendors
3.2. Strategies Adopted by Preclinical CRO Market Vendors
3.3. Key Industry Strategies
4. Preclinical CRO Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Preclinical CRO Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Bioanalysis and DMPK studies
5.3.1.1. In vitro ADME
5.3.1.2. In-vivo PK
5.3.2. Toxicology Testing
5.3.2.1. GLP
5.3.2.2. Non-GLP
5.3.3. Compound Management
5.3.3.1. Process R&D
5.3.3.2. Custom Synthesis
5.3.3.3. Others
5.3.4. Chemistry
5.3.4.1. Medicinal Chemistry
5.3.4.2. Computation Chemistry
5.3.5. Safety Pharmacology
5.3.6. Others

6. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Patient Derived Organoid (PDO) Model
6.3.2. Patient derived xenograft model

7. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Biopharmaceutical Companies
7.3.2. Government and Academic Institutes
7.3.3. Medical Device Companies


8. North America Preclinical CRO Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
8.3. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
8.4. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
8.5.Preclinical CRO Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
8.5.1.1.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
8.5.1.1.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
8.5.1.2.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
8.5.1.2.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
8.5.1.3.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
8.5.1.3.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)

9. UK and European Union Preclinical CRO Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
9.3. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
9.4. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
9.5.Preclinical CRO Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
9.5.1.1.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
9.5.1.1.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
9.5.1.2.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
9.5.1.2.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
9.5.1.3.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
9.5.1.3.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
9.5.1.4.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
9.5.1.4.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
9.5.1.5.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
9.5.1.5.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
9.5.1.6.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
9.5.1.6.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)

10. Asia Pacific Preclinical CRO Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
10.3. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
10.4. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
10.5.Preclinical CRO Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
10.5.1.1.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
10.5.1.1.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
10.5.1.2.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
10.5.1.2.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
10.5.1.3.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
10.5.1.3.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
10.5.1.4.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
10.5.1.4.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
10.5.1.5.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
10.5.1.5.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
10.5.1.6.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
10.5.1.6.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)

11. Latin America Preclinical CRO Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
11.3. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
11.4. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
11.5.Preclinical CRO Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
11.5.1.1.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
11.5.1.1.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
11.5.1.2.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
11.5.1.2.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
11.5.1.3.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
11.5.1.3.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)

12. Middle East and Africa Preclinical CRO Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
12.3. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
12.4. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
12.5.Preclinical CRO Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
12.5.1.1.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
12.5.1.1.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
12.5.1.2.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
12.5.1.2.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Preclinical CRO Market: By Service, 2022-2032, USD (Million)
12.5.1.3.2. Preclinical CRO Market: By Model Type, 2022-2032, USD (Million)
12.5.1.3.3. Preclinical CRO Market: By End-Use, 2022-2032, USD (Million)

13. Company Profile
13.1. Covance Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Charles River Laboratories International, Inc.
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Syngene International Limited
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Eurofins Scientific
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. PRA Health Sciences, Inc.
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Wuxi AppTec
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Medpace, Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. PPD (Thermo Fisher Scientific, Inc.)
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. SGA SA
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Intertek Group Plc (IGP)
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. LABCORP
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Crown Bioscience
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Other Notable Players
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives